| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014NatCo...5.3037C |
| P6179 | Dimensions Publication ID | 1007507073 |
| P356 | DOI | 10.1038/NCOMMS4037 |
| P3181 | OpenCitations bibliographic resource ID | 3797889 |
| P932 | PMC publication ID | 4082030 |
| P698 | PubMed publication ID | 24390130 |
| P2093 | author name string | Chunyu Wang | |
| David J Rosenman | |||
| Wen Chen | |||
| Yue-Ming Li | |||
| Jian Xie | |||
| Maria M Lopez | |||
| Eric Gamache | |||
| P2860 | cites work | The mechanism of γ-Secretase dysfunction in familial Alzheimer disease | Q36000134 |
| Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons | Q36324215 | ||
| Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 --> Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease | Q36459592 | ||
| Structural studies of the transmembrane C-terminal domain of the amyloid precursor protein (APP): does APP function as a cholesterol sensor? | Q36948254 | ||
| A helix-to-coil transition at the epsilon-cut site in the transmembrane dimer of the amyloid precursor protein is required for proteolysis | Q37083598 | ||
| Transmembrane structures of amyloid precursor protein dimer predicted by replica-exchange molecular dynamics simulations | Q37307178 | ||
| Expression, purification, and reconstitution of the transmembrane domain of the human amyloid precursor protein for NMR studies | Q39708958 | ||
| Mutations in APP have independent effects on Abeta and CTFgamma generation | Q40506128 | ||
| Amyloidogenic processing but not amyloid precursor protein (APP) intracellular C-terminal domain production requires a precisely oriented APP dimer assembled by transmembrane GXXXG motifs | Q41822677 | ||
| Shifting a complex debate on γ-secretase cleavage and Alzheimer's disease | Q41828981 | ||
| Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. | Q43697159 | ||
| Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs | Q46028454 | ||
| The amyloid precursor protein C-terminal fragment C100 occurs in monomeric and dimeric stable conformations and binds γ-secretase modulators | Q46772118 | ||
| Alzheimer's disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD production | Q47880180 | ||
| gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. | Q51776761 | ||
| An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. | Q53207278 | ||
| Familial Alzheimer's disease-linked mutations at Val717 of amyloid precursor protein are specific for the increased secretion of A beta 42(43). | Q53214445 | ||
| A simple apparatus for generating stretched polyacrylamide gels, yielding uniform alignment of proteins and detergent micelles | Q77587741 | ||
| Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE | Q22010705 | ||
| Purification and cloning of amyloid precursor protein beta-secretase from human brain | Q22010914 | ||
| Purification and characterization of the human gamma-secretase complex | Q24300026 | ||
| Dimeric structure of transmembrane domain of amyloid precursor protein in micellar environment | Q24321998 | ||
| The Amyloid Precursor Protein Has a Flexible Transmembrane Domain and Binds Cholesterol | Q27679405 | ||
| A transmembrane helix dimer: structure and implications | Q27735013 | ||
| Automated NMR structure calculation with CYANA | Q27860754 | ||
| The Xplor-NIH NMR molecular structure determination package | Q27860805 | ||
| NMRPipe: a multidimensional spectral processing system based on UNIX pipes | Q27860859 | ||
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
| Evaluating protein structures determined by structural genomics consortia | Q29547577 | ||
| Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease | Q29614374 | ||
| High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation | Q29616564 | ||
| Take five--BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. | Q30336360 | ||
| Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease | Q30955688 | ||
| Liquid crystalline phase of G-tetrad DNA for NMR study of detergent-solubilized proteins | Q31156343 | ||
| GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42. | Q33276402 | ||
| Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants | Q33317424 | ||
| Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif | Q33572654 | ||
| A cell biological perspective on Alzheimer's disease | Q34141335 | ||
| Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. | Q34148927 | ||
| Evidence from solid-state NMR for nonhelical conformations in the transmembrane domain of the amyloid precursor protein | Q34535890 | ||
| {gamma}-Secretase Substrate Concentration Modulates the Abeta42/Abeta40 Ratio: IMPLICATIONS FOR ALZHEIMER DISEASE. | Q34635580 | ||
| Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling | Q34810184 | ||
| Molecular determinants and thermodynamics of the amyloid precursor protein transmembrane domain implicated in Alzheimer's disease. | Q34856213 | ||
| Mechanism of the cleavage specificity of Alzheimer's disease gamma-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein | Q35065215 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 3037 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | Familial Alzheimer’s mutations within APPTM increase Aβ42 production by enhancing accessibility of ε-cleavage site | |
| P478 | volume | 5 |
| Q27011749 | Alzheimer's disease--a panorama glimpse |
| Q37195665 | Alzheimer's disease-associated mutations increase amyloid precursor protein resistance to γ-secretase cleavage and the Aβ42/Aβ40 ratio |
| Q46143639 | Backbone Hydrogen Bond Strengths Can Vary Widely in Transmembrane Helices. |
| Q52714855 | Binding of Bexarotene to the Amyloid Precursor Protein Transmembrane Domain in Liposomes Alters its α-Helical Conformation but Inhibits γ-Secretase Non-Selectively. |
| Q58771128 | Coupled Transmembrane Substrate Docking and Helical Unwinding in Intramembrane Proteolysis of Amyloid Precursor Protein |
| Q36668200 | Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models |
| Q89387446 | Dissecting conformational changes in APP's transmembrane domain linked to ε-efficiency in familial Alzheimer's disease |
| Q47122462 | Dominant negative effect of the loss-of-function γ-secretase mutants on the wild-type enzyme through heterooligomerization |
| Q36801644 | Evolutionary-guided de novo structure prediction of self-associated transmembrane helical proteins with near-atomic accuracy |
| Q36470096 | Extension of a protein docking algorithm to membranes and applications to amyloid precursor protein dimerization. |
| Q90661748 | Helix-Switch Enables C99 Dimer Transition between the Multiple Conformations |
| Q38912992 | How amyloid precursor protein protects itself from cleavage. |
| Q37247599 | Impact of membrane lipid composition on the structure and stability of the transmembrane domain of amyloid precursor protein. |
| Q64105395 | Increased H-Bond Stability Relates to Altered ε-Cleavage Efficiency and Aβ Levels in the I45T Familial Alzheimer's Disease Mutant of APP |
| Q64972059 | Influence of the familial Alzheimer's disease-associated T43I mutation on the transmembrane structure and γ-secretase processing of the C99 peptide. |
| Q36810822 | Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders |
| Q54979674 | Mechanism of Allosteric Coupling into and through the Plasma Membrane by EGFR. |
| Q64087524 | Processing of Mutant β-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer's Disease |
| Q30379691 | Structural Mechanism of the Interaction of Alzheimer Disease Aβ Fibrils with the Non-steroidal Anti-inflammatory Drug (NSAID) Sulindac Sulfide |
| Q33926425 | Structural heterogeneity in transmembrane amyloid precursor protein homodimer is a consequence of environmental selection |
| Q91595678 | Structure determination protocol for transmembrane domain oligomers |
| Q51760979 | The Role of microRNAs in Alzheimer's Disease and Their Therapeutic Potentials. |
| Q54254035 | The Unusual Transmembrane Partition of the Hexameric Channel of the Hepatitis C Virus. |
| Q41895349 | The amyloid-beta forming tripeptide cleavage mechanism of γ-secretase. |
Search more.